The nation of Zimbabwe has rejected a major American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over the United States' insistence on sensitive biological samples.
This rejection became public after a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesman later explained that the US was demanding access to health data for research and commercial purposes while was not willing to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for further dialogue to find a agreement suitable to both sides so the nation's vital HIV treatment initiative can continue.
Wider Background
This development comes after a similar case in neighbouring Kenya, where a high court suspended a similar health funding agreement following concerns were raised about the security of Kenyans' health data.
Since resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance transparency and accountability.
As per statements, 16 African countries have so far agreed to these new agreements, representing over $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent guarantee of access to any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.
"Put simply, our country would supply the raw materials for medical research without any assurance that the final treatments would be accessible to our citizens should a future disease outbreak arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending systems previously established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with potential pandemics.
"This mechanism is designed to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how subsequent collaboration might be structured in a way that honours the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body said it recognised the official position, but recommended that talks need to persist considering much of the nation's HIV programmes depended on international support.
"In cases where technical issues exist, including those relating to data governance or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," it said.
This impasse underscores the ongoing debate between accepting much-needed international aid and safeguarding a country's data in an ever more interconnected world.